Literature DB >> 3089495

Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study.

G Rose, M Shipley.   

Abstract

Ten year mortality from coronary heart disease in 17,718 middle aged men was related to their initial plasma cholesterol concentrations. The relative risk of death from coronary heart disease declined with age, but the absolute excess risk did not. The risk gradient was continuous over the whole range of cholesterol concentrations, the lowest mortality being among men with concentrations below the lowest decile. It seems that, as with blood pressure, the average cholesterol concentration in the blood pressure, the average cholesterol concentration in the population is too high: lowest concentrations are prognostically the best. A quarter of all deaths from coronary heart disease related to cholesterol occurred among men with concentrations above the top decile, but 55% occurred among men with concentrations in the middle three fifths of the distribution; this figure of 55% could be reduced only by a policy aimed at lowering concentrations in the whole population.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089495      PMCID: PMC1340986          DOI: 10.1136/bmj.293.6542.306

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  3 in total

1.  Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention.

Authors:  D D Reid; G Z Brett; P J Hamilton; R J Jarrett; H Keen; G Rose
Journal:  Lancet       Date:  1974-03-23       Impact factor: 79.321

2.  Strategy of prevention: lessons from cardiovascular disease.

Authors:  G Rose
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-06

3.  Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years.

Authors:  J D Neaton; L H Kuller; D Wentworth; N O Borhani
Journal:  Am Heart J       Date:  1984-09       Impact factor: 4.749

  3 in total
  27 in total

1.  The Vale of Leven health promotion project.

Authors:  A S Harper; M R Farrally; A M Emery; T J McGlew; A Lyon; G Docherty; M Russell
Journal:  Br J Gen Pract       Date:  1990-02       Impact factor: 5.386

2.  Environmental factors and disease: the man made environment.

Authors:  G Rose
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-11

Review 3.  Adverse effects of inhaled corticosteroids.

Authors:  R J Stead; N J Cooke
Journal:  BMJ       Date:  1989-02-18

Review 4.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

5.  Changes in blood pressure and body weight over ten years in men selected for glucose intolerance.

Authors:  R J Jarrett; H Keen; T Murrells
Journal:  J Epidemiol Community Health       Date:  1987-06       Impact factor: 3.710

Review 6.  Dietary fat and coronary heart disease.

Authors:  M F Oliver
Journal:  Br Heart J       Date:  1987-11

7.  Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects.

Authors:  Y T Kruszynska; M Greenstone; P D Home; N J Cooke
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

8.  Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

Authors:  J M Heery; M Kozak; D M Stafforini; D A Jones; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

10.  Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.

Authors:  Z Chen; R Peto; R Collins; S MacMahon; J Lu; W Li
Journal:  BMJ       Date:  1991-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.